ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

NVS Novartis AG

97.27
-0.07 (-0.07%)
04 May 2024 - Closed
Delayed by 15 minutes
Name Symbol Market Type
Novartis AG NYSE:NVS NYSE Depository Receipt
  Price Change % Change Price High Price Low Price Open Price Traded Last Trade
  -0.07 -0.07% 97.27 97.91 97.07 97.75 1,045,674 01:00:00

ADR Shares End Higher; Noah Education Shares Active

02/04/2014 9:55pm

Dow Jones News


Novartis (NYSE:NVS)
Historical Stock Chart


From May 2019 to May 2024

Click Here for more Novartis Charts.

International stocks trading in New York closed higher on Wednesday, with the Bank of New York index of American depositary receipts adding 0.3% to 152.34. The European index was essentially flat at 152.02, the Asian index added 0.4% to 144.34, the Latin American index jumped 2.1% to 285.37 and the emerging markets index rose 0.8% to 278.17. Among the companies with shares that actively traded was Noah Education Holdings Ltd. (NED).

Noah Education, a leading provider of education services in China, agreed to a boosted takeover bid that values the company at about $107 million. Some of the shareholders of the China-based education company, including an affiliate of Morgan Stanley's (MS) private equity arm in Asia, have offered $2.85 a share to buy out the company, up five cents a share from December's bid. Shares rose 1.9% to $2.75.

The board of directors of Brazilian phone company Oi SA (OIBR, OIBR4.BR) has authorized the issuance of up to a maximum 7.8 billion in new shares, worth some 23.6 billion Brazilian reais ($10.38 billion) at today's market price, as part of its plan to merge with Portugal Telecom SGPS SA (PT, PTC.LB). Oi shares added 4.6% to $1.36.

A third-party probe into the Japanese unit of Swiss drug giant Novartis AG (NVS, NOVN.VX) said its staff tried to cover up evidence and were involved in a number of questionable activities, but concluded that data wasn't falsified in clinical research into leukemia treatments. Shares edged up 0.1% to $84.57.

In the latest of a string of recent drug-development setbacks, GlaxoSmithKline PLC (GSK, GSK.LN) stopped a late-stage trial of its cancer vaccine after a series of disappointing results. Shares slipped 0.6% to $53.00.

Brazilian mining company Vale SA (VALE, VALE3.BR, VALE5.BR) said Wednesday it has suspended coal shipments from its mines in Mozambique after a train conductor was injured in an attack that authorities are blaming on former rebel group Renamo. Shares still rose 4% to $14.34.

Write to Anna Prior at anna.prior@wsj.com

Subscribe to WSJ: http://online.wsj.com?mod=djnwires


1 Year Novartis Chart

1 Year Novartis Chart

1 Month Novartis Chart

1 Month Novartis Chart

Your Recent History

Delayed Upgrade Clock